Cargando…
Dilemma of HCV Infection in Renal Transplant Recipients
Hepatitis C virus, which usually starts during dialysis therapy, is currently the main cause of chronic liver disease in such population. The majority of patients acquired the disease through intravenous drug use or blood transfusion, with some risk factors identified. In this review we are dealing...
Autor principal: | Ashry Ahmed Gheith, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108094/ https://www.ncbi.nlm.nih.gov/pubmed/21660304 http://dx.doi.org/10.4061/2011/471214 |
Ejemplares similares
-
Gene Expression Profiling in Organ Transplantation
por: Gheith, Osama Ashry Ahmed
Publicado: (2011) -
Medication compliance and lifestyle adherence in renal transplant recipients in Kuwait
por: Kenawy, Ahmed Saleh, et al.
Publicado: (2019) -
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
por: Sabbatini, Massimo, et al.
Publicado: (2018) -
HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs
por: Fernandes, A. R., et al.
Publicado: (2017) -
Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)